RBC Capital analyst Sabahat Khan raised the firm's price target on WM to $240 from $235 and keeps a Sector Perform rating on the shares. The company reported a mixed Q1 but continues to make progress on the Stericycle integration and its sustainability investments, with the bigger picture trends remaining largely intact, the analyst tells investors in a research note.
